Abstract
Portielje et al[1][1] recently reported a study on the natural history of idiopathic thrombocytopenic purpura (ITP). Although the design of their study still falls short of a “gold-standard” inception cohort, prospective study required to reliably assess the natural history of a disease,[2][2]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
